PIK3CA and non-small cell lung carcinoma: Increased expression of the mediators of PI3 kinase (PI3K) pathway is one of these changes31.We thus asked whether there are associations between miR-1 levels and expression of PI3 kinase (PI3K) pathway mediators in the lungs of patients with NSCLC.